Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Breast 1

Conditions

Multiple Myeloma 7Breast Neoplasms 6Neoplasms, Plasma Cell 5Neoplasm Metastasis 3Pain 2Spondylitis, Ankylosing 1Prostatic Neoplasms 1Bone Diseases 1

Interventions

Fentanyl 27Analgesia 23Morphine 20Acupuncture Therapy 18Surveys and Questionnaires 16Oxycodone 16Zoledronic Acid 15Acetaminophen 14Therapeutics 13Radiotherapy 13Psychiatric Rehabilitation 13Ketamine 13Methadone 11Lidocaine 11Hydromorphone 11Bupivacaine 11nabiximols 10Ibandronic Acid 10Ropivacaine 9Early Intervention, Educational 7Analgesics, Opioid 7Saline Solution 6Music Therapy 6Cryotherapy 6Cryosurgery 6Yoga 5Water 5Tapentadol 5Pregabalin 5Methods 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pain × Pamidronate × Clear all
NCT00482378 2018-08-14

Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain

Mayo Clinic

Phase 1/2 Completed
39 enrolled
Plasma cell

Multiple Myeloma, Pain, Neoplasms, Plasma Cell

NCT01907880 2017-07-07

ER11-03

Ottawa Hospital Research Institute

Phase 4 Completed
74 enrolled
Breast

Breast Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡